{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:29:57Z","timestamp":1791242997453,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T00:00:00Z","timestamp":1371168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0065068","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T21:27:00Z","timestamp":1371245220000},"page":"e65068","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms"],"prefix":"10.1371","volume":"8","author":[{"given":"\u00c8lia","family":"Ripoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Goma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"de Ramon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculada","family":"Herrero-Fresneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Bestard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Cruzado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Griny\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Torras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,6,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/BOR.0b013e32832efff1","article-title":"Pathogenesis of kidney disease in systemic lupus erythematosus","volume":"21","author":"H Bagavant","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1365-2222.2001.01147.x","article-title":"Pathogenesis of systemic lupus erythematosus (SLE)","volume":"31","author":"MG Robson","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"ref3","first-page":"233","article-title":"Lupus nephritis: consequence of disturbed removal of apoptotic cells?","volume":"61","author":"JH Berden","year":"2003","journal-title":"Neth J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrrheum.2009.240","article-title":"Lupus nephritis: lessons from murine models","volume":"6","author":"A Davidson","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.4049\/jimmunol.149.9.3083","article-title":"Development of murine lupus in CD4-depleted NZB\/NZW mice. Sustained inhibition of residual CD4+ T cells is required to suppress autoimmunity","volume":"149","author":"K Connolly","year":"1992","journal-title":"J Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD154 in cell-mediated immunity","volume":"16","author":"IS Grewal","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2003.tb06048.x","article-title":"Co-stimulatory blockade in the treatment of murine systemic lupus erythematosus (SLE)","volume":"987","author":"A Davidson","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"ref8","first-page":"1280","article-title":"Cyclophosphamide treatment of kidney disease in (NZB x NZW) F1 mice","volume":"1","author":"PJ Russell","year":"1966","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/art.20147","article-title":"Prevention of renal damage in murine lupus nephritis by CTLA-4Ig and cyclophosphamide","volume":"50","author":"G Cunnane","year":"2004","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1523-1755.2000.00832.x","article-title":"Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide","volume":"57","author":"JP Ioannidis","year":"2000","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-0-12-394596-9.00010-X","article-title":"Animal models of molecular pathology systemic lupus erythematosus","volume":"105","author":"A Sang","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref12","first-page":"289","article-title":"Animal models of human systemic lupus erythematosus","volume":"52","author":"DP Huston","year":"1979","journal-title":"Yale J Biol Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/sarh.2000.7173","article-title":"The pathogenesis of autoimmunity in New Zealand mice","volume":"29","author":"A Borchers","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/096120301682430140","article-title":"Lessons in lupus: the mighty mouse","volume":"10","author":"BH Hahn","year":"2001","journal-title":"Lupus"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4049\/jimmunol.171.1.489","article-title":"Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB\/W F1 mice by a mechanism downstream of renal immune complex deposition","volume":"171","author":"L Schiffer","year":"2003","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.4049\/jimmunol.168.4.2046","article-title":"Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus","volume":"168","author":"X Wang","year":"2002","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/72162","article-title":"Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand","volume":"6","author":"T Kawai","year":"2000","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4049\/jimmunol.0903888","article-title":"Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice","volume":"185","author":"L Robles-Carrillo","year":"2010","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1182\/blood-2005-02-0759","article-title":"LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia","volume":"106","author":"H Qin","year":"2005","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"H631","DOI":"10.1152\/ajpheart.00733.2005","article-title":"Differential expression and regulation of murine CD40 in regional vascular beds","volume":"290","author":"T Vowinkel","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1261\/rna.5239604","article-title":"In vivo activity of nuclease-resistant siRNAs","volume":"10","author":"JM Layzer","year":"2004","journal-title":"RNA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2006.02.049","article-title":"Chemical modification of siRNAs to improve serum stability without loss of efficacy","volume":"342","author":"S Choung","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/jm049167j","article-title":"Fully 2\u2032-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA","volume":"48","author":"CR Allerson","year":"2005","journal-title":"J Med Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1172\/JCI33483","article-title":"Chemical modification: the key to clinical application of RNA interference?","volume":"117","author":"DR Corey","year":"2007","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","article-title":"Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs","volume":"432","author":"J Soutschek","year":"2004","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/gt.2011.39","article-title":"In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection","volume":"18","author":"E Ripoll","year":"2011","journal-title":"Gene Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood-2008-03-143305","article-title":"CD40: an upstream master switch for endothelial cell activation uncovered by RNAi-coupled transcriptional profiling","volume":"112","author":"R Pluvinet","year":"2008","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1681\/ASN.2010050515","article-title":"Local renal autoantibody production in lupus nephritis","volume":"22","author":"M Espeli","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"AL Peters","year":"2009","journal-title":"Semin Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1172\/JCI114831","article-title":"Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease","volume":"86","author":"DM Klinman","year":"1990","journal-title":"J Clin Invest"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","article-title":"Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus","volume":"165","author":"M Odendahl","year":"2000","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/intimm\/dxn031","article-title":"Regulatory role of B-1 B cells in chronic colitis","volume":"20","author":"Y Shimomura","year":"2008","journal-title":"Int Immunol"},{"key":"ref33","first-page":"283","article-title":"Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus","volume":"16","author":"YB Park","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.181.3.839","article-title":"Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"L Llorente","year":"1995","journal-title":"J Exp Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: new perspectives on an old cytokine","volume":"226","author":"DM Mosser","year":"2008","journal-title":"Immunol Rev"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H","article-title":"Inflamed kidneys of NZB\/W mice are a major site for the homeostasis of plasma cells","volume":"31","author":"G Cassese","year":"2001","journal-title":"Eur J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/eji.201041315","article-title":"High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB\/W F1 lupus mice","volume":"41","author":"C Starke","year":"2011","journal-title":"Eur J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molimm.2011.09.015","article-title":"The dual role of complement in the progression of renal disease in NZB\/W F(1) mice and alternative pathway inhibition","volume":"49","author":"H Sekine","year":"2011","journal-title":"Mol Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.immunol.22.012703.104549","article-title":"The role of complement in the development of systemic lupus erythematosus","volume":"22","author":"AP Manderson","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.4049\/jimmunol.162.7.4336","article-title":"Contribution of renal secreted complement C3 to the circulating pool in humans","volume":"162","author":"S Tang","year":"1999","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ncb1038","article-title":"Activation of the interferon system by short-interfering RNAs","volume":"5","author":"CA Sledz","year":"2003","journal-title":"Nat Cell Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"L Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1261\/rna.2340906","article-title":"Induction of the interferon response by siRNA is cell type- and duplex length-dependent","volume":"12","author":"A Reynolds","year":"2006","journal-title":"RNA"}],"updated-by":[{"DOI":"10.1371\/annotation\/8494360d-8ab1-4575-8a01-fb288ffde976","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T00:00:00Z","timestamp":1376956800000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0065068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T11:33:20Z","timestamp":1688297600000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0065068"}},"subtitle":[],"editor":[{"given":"Andreas","family":"Zirlik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,14]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0065068","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,14]]}}}